Ruiyan Wu

3PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 30, 2025
Organ Preservation via Immunotherapy-Based Total Neoadjuvant Therapy in Early Low Rectal Cancer (TORCH-E): A Multicenter, Open-label, Single-Arm, Phase II Study.

Fan Xia, Yajie Chen, Di Zhou

|Jul 01, 2024
Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH).

Fan Xia, Yaqi Wang, Hui Wang

|Nov 07, 2020
SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA.

Ruiyan Wu, Caiqin Wang, Zhiming Li

Pageof 1

Frequent Collaborators

2 joint publications

Fan Xia

2 joint publications

Yaqi Wang

2 joint publications

Menglong Zhou

1 joint publications

Jingwen Wang